KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Capital Employed: 2018-2025

Historic Return on Capital Employed for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Sep 2025 value amounting to 0.14%.

  • Amneal Pharmaceuticals' Return on Capital Employed rose 6.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 6.00%. This contributed to the annual value of 0.11% for FY2024, which is 3.00% up from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Return on Capital Employed of 0.14% as of Q3 2025, which was down 17.91% from 0.16% recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Capital Employed registered a high of 0.16% during Q2 2025, and its lowest value of -0.05% during Q2 2022.
  • For the 3-year period, Amneal Pharmaceuticals' Return on Capital Employed averaged around 0.09%, with its median value being 0.08% (2023).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first fell by 9bps in 2022, then rose by 12bps in 2023.
  • Amneal Pharmaceuticals' Return on Capital Employed (Quarterly) stood at 0.05% in 2021, then fell by 8bps to -0.03% in 2022, then increased by 11bps to 0.07% in 2023, then increased by 3bps to 0.11% in 2024, then climbed by 6bps to 0.14% in 2025.
  • Its Return on Capital Employed was 0.14% in Q3 2025, compared to 0.16% in Q2 2025 and 0.15% in Q1 2025.